New Sub-Phenotyping of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications?

被引:0
|
作者
Djordje S. Popovic
Manfredi Rizzo
Edita Stokic
Nikolaos Papanas
机构
[1] Clinical Center of Vojvodina,Clinic for Endocrinology, Diabetes and Metabolic Disorders
[2] University of Novi Sad,Medical Faculty
[3] University of Palermo,Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties of Internal Medicine (Promise), School of Medicine
[4] University Hospital of Alexandroupolis,Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace
来源
Diabetes Therapy | 2021年 / 12卷
关键词
Cardiovascular disease; Diabetes mellitus; Kidney disease; Precision medicine; Prediabetes; Type 2 diabetes mellitus;
D O I
暂无
中图分类号
学科分类号
摘要
Prediabetes is defined as a condition of abnormal glucose metabolism, characterised by plasma glucose above normal range but not as high as required for the diagnosis of diabetes mellitus (DM). It represents a heterogeneous entity of intermediate glucose metabolism, including impaired fasting glucose, impaired glucose tolerance, and borderline glycated haemoglobin. Prediabetes is being increasingly recognised as an important metabolic state not only predisposing to a higher probability of future progression to DM, but also to an increased risk of different micro- and macrovascular complications. The recently proposed sub-phenotyping of individuals at increased risk of type 2 DM, which distinguishes six different clusters, offers the opportunity for the improvement in screening, prevention, and treatment algorithms. Such progress should also enable more efficient and cost-effective strategies aimed at decreasing the disease burden associated with prediabetes.
引用
收藏
页码:1605 / 1611
页数:6
相关论文
共 50 条
  • [1] New Sub-Phenotyping of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications?
    Popovic, Djordje S.
    Rizzo, Manfredi
    Stokic, Edita
    Papanas, Nikolaos
    DIABETES THERAPY, 2021, 12 (06) : 1605 - 1611
  • [2] Genetics of type 2 diabetes and potential clinical implications
    Soo Heon Kwak
    Kyong Soo Park
    Archives of Pharmacal Research, 2013, 36 : 167 - 177
  • [3] Genetics of type 2 diabetes and potential clinical implications
    Kwak, Soo Heon
    Park, Kyong Soo
    ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (02) : 167 - 177
  • [4] Pharmacogenetics in type 2 diabetes: potential implications for clinical practice
    Huang, Chunmei
    Florez, Jose C.
    GENOME MEDICINE, 2011, 3
  • [5] Pharmacogenetics in type 2 diabetes: potential implications for clinical practice
    Chunmei Huang
    Jose C Florez
    Genome Medicine, 3
  • [6] Statins and risk of type 2 diabetes: mechanism and clinical implications
    Laakso, Markku
    Fernandes Silva, Lilian
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [7] The absence of longitudinal data limits the accuracy of high-throughput clinical phenotyping for identifying type 2 diabetes mellitus subjects
    Wei, Wei-Qi
    Leibson, Cynthia L.
    Ransom, Jeanine E.
    Kho, Abel N.
    Chute, Christopher G.
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2013, 82 (04) : 239 - 247
  • [8] Clinical phenotyping of newly diagnosed type 2 diabetes in Yemen
    Gunaid, Abdallah Ahmed
    Al-Kebsi, Mohammed Mohammed
    Bamashmus, Mahfouth Abdalla
    Al-Akily, Saleh Ahmed
    Al-Radaei, Ahmed Nasser
    BMJ OPEN DIABETES RESEARCH & CARE, 2018, 6 (01)
  • [9] Sex Differences in the Excess Risk of Cardiovascular Diseases Associated with Type 2 Diabetes: Potential Explanations and Clinical Implications
    Peters S.A.E.
    Huxley R.R.
    Sattar N.
    Woodward M.
    Current Cardiovascular Risk Reports, 2015, 9 (7) : 1 - 7
  • [10] The intake of potatoes and glucose metabolism in subjects at high risk for Type 2 diabetes
    Ylonen, S. K.
    Virtanen, S. M.
    Groop, L.
    DIABETIC MEDICINE, 2007, 24 (09) : 1049 - 1050